Skip to main content

Table 3 Electrophysiologic Characteristics and ablation result of AP-MA VAs

From: Electrocardiographic and electrophysiological characteristics of idiopathic ventricular arrhythmias with acute successful ablation at the superior portion of the mitral annulus

Pt. no.

Pre-potential

A/V ratio during sinus rhythm

R/S ratio during unipolar recording

QRS-Uni (ms)

Perfect pace match

Stimulus-to-QRS interval

V-QRS interval (ms)

RFCA start to effect (s)

Recurrence during 3 days of monitoring

Recurrence during 1 year of follow up

1

No

0.21

0.19

52

No

0

54

8.1

Yes

No

2

No

0.28

0.00

0

No

0

0

17.3

No

Yes

3

No

0.35

0.31

7

No

0

15

7.7

No

No

4

No

0.03

0.22

47

No

0

18

4.2

No

No

5

No

0.05

0.00

6

No

0

31

16.5

No

No

6

No

0.58

0.09

30

No

0

0

17.3

No

No

7

No

0.03

0.00

25

No

0

5

30.2

No

Yes

8

No

0.16

0.00

12

Yes

0

7

N/A

No

No

9

No

0.46

0.00

24

Yes

0

50

19.3

No

Yes

10

No

0.04

0.00

8

Yes

0

12

9.2

No

No

11

No

0.31

0.00

22

No

0

0

5.59

No

No

12

No

0.10

0.10

16

No

0

14

21.3

No

No

13

Yes

0.43

0.07

40

No

26

0

17.4

Yes

No

14

No

0.33

0.00

26

No

0

17

19.1

Yes

Yes

15

No

0.05

0.00

17

No

0

14

17.5

No

No

16

No

0.21

0.00

12

Yes

0

0

3.2

Yes

No

17

No

0.43

0.00

8

No

0

7

20.1

No

No

18

No

0.04

0.00

15

No

0

0

23.1

Yes

Yes

19

No

0.22

0.00

28

Yes

0

9

21.7

No

No

20

No

0.22

0.00

24

Yes

0

12

14.4

No

No

21

No

0.19

0.00

9

Yes

0

10

5.6

No

No

22

No

0.13

0.00

0

Yes

0

9

13.2

No

No

23

No

0.28

0.00

0

Yes

0

14

5.4

Yes

Yes

24

No

0.29

0.00

24

No

0

6

N/A

No

Yes

25

No

0.28

0.00

12

No

0

37

8.5

No

No

26

No

0.23

0.02

25

No

0

25

N/A

No

No

Mean ± SD or percent

3.8%

0.23 ± 0.15

0.00–0.03 (0.00)*

18.8 ± 13.6

34.6%

 

3.75–17.3 (11)*

14.1 ± 7.2#

23.1%

26.9%

  1. Values are given as the mean ± SD (range) or percent (%), unless otherwise indicated. N/A: Time to effect were not available due to infrequently episode of VAs during ablation
  2. #The RFCA start-to-effect time of 14.1 ± 7.2 s were for the 23 patients (88.5%), in the remaining 3 patients (11.5%), the mean duration of successful RFCA was not well determined due to infrequent nature of clinical VAs during ablation